196 related articles for article (PubMed ID: 23983774)
21. Viability of Lucilia sericata maggots after exposure to wound antiseptics.
Daeschlein G; Napp M; Assadian O; von Podewils S; Reese K; Hinz P; Matiasek J; Spitzmueller R; Humphreys P; Jünger M; Kramer A
Int Wound J; 2017 Jun; 14(3):512-515. PubMed ID: 27396987
[TBL] [Abstract][Full Text] [Related]
22. A molecular approach to maggot debridement therapy with Lucilia sericata and its excretions/secretions in wound healing.
Tombulturk FK; Kanigur-Sultuybek G
Wound Repair Regen; 2021 Nov; 29(6):1051-1061. PubMed ID: 34343386
[TBL] [Abstract][Full Text] [Related]
23. Variables Associated with Attitudes toward Biodebridement Using
Bazaliński D; Pytlak K; Przybek-Mita J; Szymańska P; Wójcik A; Zymon A; Sherman R; Nguyen A; Sałacińska I; Więch P
Healthcare (Basel); 2023 Dec; 11(23):. PubMed ID: 38063649
[TBL] [Abstract][Full Text] [Related]
24. Midgut lysozymes of Lucilia sericata - new antimicrobials involved in maggot debridement therapy.
Valachova I; Takac P; Majtan J
Insect Mol Biol; 2014 Dec; 23(6):779-87. PubMed ID: 25098233
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Maggot Debridement Therapy on Refractory Atypical Diabetic Foot Ulcers: An Open-Label Study.
Siavash M; Najjarnezhad A; Mohseni N; Abtahi SM; Karimy A; Sabzevari MH
Int J Low Extrem Wounds; 2021 Dec; 20(4):315-320. PubMed ID: 32370633
[TBL] [Abstract][Full Text] [Related]
26. [Maggots of Lucilia sericata in treatment of intractable wounds].
Orkiszewski M
Wiad Lek; 2007; 60(7-8):381-5. PubMed ID: 18175560
[TBL] [Abstract][Full Text] [Related]
27. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
[TBL] [Abstract][Full Text] [Related]
28. Perception and Readiness to Undertake Maggot Debridement Therapy with the Use of
Bazaliński D; Przybek Mita J; Ścisło L; Więch P
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270587
[TBL] [Abstract][Full Text] [Related]
29. Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots.
Andersen AS; Joergensen B; Bjarnsholt T; Johansen H; Karlsmark T; Givskov M; Krogfelt KA
Microbiology (Reading); 2010 Feb; 156(Pt 2):400-407. PubMed ID: 19892758
[TBL] [Abstract][Full Text] [Related]
30. A Survey on Inhibitory Effect of Whole-Body Extraction and Secretions of
Tahmasebi M; Soleimanifard S; Sanei A; Karimy A; Abtahi SM
Adv Biomed Res; 2020; 9():12. PubMed ID: 32318361
[TBL] [Abstract][Full Text] [Related]
31. Maggot therapy for the treatment of intractable wounds.
Mumcuoglu KY; Ingber A; Gilead L; Stessman J; Friedmann R; Schulman H; Bichucher H; Ioffe-Uspensky I; Miller J; Galun R; Raz I
Int J Dermatol; 1999 Aug; 38(8):623-7. PubMed ID: 10487456
[TBL] [Abstract][Full Text] [Related]
32. Microbiological effects in patients with leg ulcers and diabetic foot treated with Lucilia sericata larvae.
Szczepanowski Z; Grabarek BO; Boroń D; Tukiendorf A; Kulik-Parobczy I; Miszczyk L
Int Wound J; 2022 Jan; 19(1):135-143. PubMed ID: 33942509
[TBL] [Abstract][Full Text] [Related]
33. A human tissue-based assay identifies a novel carrion blowfly strain for maggot debridement therapy.
Yoshida T; Aonuma H; Otsuka S; Ichimura H; Saiki E; Hashimoto K; Ote M; Matsumoto S; Iwadate K; Miyawaki T; Kanuka H
Sci Rep; 2022 Jul; 12(1):12191. PubMed ID: 35842442
[TBL] [Abstract][Full Text] [Related]
34. Scanning electron microscopic evaluation of the successful sterilization of Lucilia cuprina (Wiedemann) utilized in maggot debridement therapy (mdt).
Yeong YS; Nazni WA; Santana RL; Mohd Noor I; Lee HL; Mohd Sofian A
Trop Biomed; 2011 Aug; 28(2):325-32. PubMed ID: 22041752
[TBL] [Abstract][Full Text] [Related]
35. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility of antimicrobials to maggot debridement therapy: medical maggots Lucilia sericata (Diptera: Calliphoridae) exhibit tolerance to clinical maximum doses of antimicrobials.
Peck GW; Kirkup BC
J Med Entomol; 2012 Sep; 49(5):1137-43. PubMed ID: 23025196
[TBL] [Abstract][Full Text] [Related]
37. Changing attitudes toward maggot debridement therapy in wound treatment: a review and discussion.
King C
J Wound Care; 2020 Feb; 29(Sup2c):S28-S34. PubMed ID: 32058840
[TBL] [Abstract][Full Text] [Related]
38. Does maggot therapy promote wound healing? The clinical and cellular evidence.
Nigam Y; Morgan C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):776-82. PubMed ID: 26691053
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Chronic Wound Debridement with the Use of Larvae of
Bazaliński D; Kózka M; Karnas M; Więch P
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31684038
[TBL] [Abstract][Full Text] [Related]
40. Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models.
Sanei-Dehkordi A; Khamesipour A; Akbarzadeh K; Akhavan AA; Mir Amin Mohammadi A; Mohammadi Y; Rassi Y; Oshaghi MA; Alebrahim Z; Eskandari SE; Rafinejad J
Exp Parasitol; 2016 Nov; 170():59-65. PubMed ID: 27567983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
